E319

E319

SCHEMBL6507343

CC(C)(C)OC(=O)COc1ccc(O)c(C(C)(C)C)c1.CC(C)(C)c1cc(O)ccc1O

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.53
LMNA P02545 2/20 0.53
NR1I2 O75469 1/20 0.53
CYP2C9 P11712 1/20 0.53
MIF P14174 1/20 0.53
TYR P14679 1/20 0.53
ALOX15 P16050 1/20 0.53
HTT P42858 1/20 0.53
NFE2L2 Q16236 1/20 0.53
HSD17B10 Q99714 1/20 0.53
GAA P10253 2/20 0.51
ESRRA P11474 2/20 0.46
MAPT P10636 2/20 0.44
NR1H4 Q96RI1 4/20 0.43
ATM Q13315 2/20 0.43
XBP1 P17861 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
THRA P10827 1/20 0.42
THRB P10828 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5373274 0.95 ALDH1A1 (0.50) ALDH1A1LMNANR1I2CYP2C9MIF
SCHEMBL5322689 0.86 MAPT (0.47) LMNACYP2C9GAAMAPTNPSR1
SCHEMBL26691695 0.84 MAPT (0.50) LMNACYP2C9GAAMAPTATM
SCHEMBL6074675 0.82 ALDH1A1 (0.51) ALDH1A1HSD17B10GAAESRRAMAPT
SCHEMBL4598237 0.80 PSEN1 (0.49) LMNAGAAMAPTL3MBTL1PSEN1
SCHEMBL25331426 0.79 ESRRA (0.57) ALDH1A1LMNANR1I2CYP2C9MIF
SCHEMBL4398454 0.79 CA2 (0.49) ALDH1A1LMNACYP2C9TYRALOX15
SCHEMBL11355629 0.79 THRA (0.59) ALDH1A1LMNAGAAESRRAMAPT
SCHEMBL30440124 0.79 ESRRA (0.57) ALDH1A1LMNANR1I2CYP2C9MIF
SCHEMBL30737444 0.79 LMNA (0.50) ALDH1A1LMNACYP2C9GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005023762-A1 PYRROLIDINE-2-CARBONITRILE DERIVATIVES AND THEIR USE AS INHIBITORS OF DIPEPTIDYL PEPTIDASE-IV (DPP-IV) ABBOTT LABORATORIES (US) 2005-03-17 WO disclosed